Yujing Wu

1.2k total citations
63 papers, 937 citations indexed

About

Yujing Wu is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yujing Wu has authored 63 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 16 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yujing Wu's work include Monoclonal and Polyclonal Antibodies Research (11 papers), T-cell and B-cell Immunology (11 papers) and Immune Cell Function and Interaction (10 papers). Yujing Wu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), T-cell and B-cell Immunology (11 papers) and Immune Cell Function and Interaction (10 papers). Yujing Wu collaborates with scholars based in China, Saint Kitts and Nevis and France. Yujing Wu's co-authors include Yan Chang, Wei Wei, Lingling Zhang, Wei Wei, Huaxun Wu, Qingtong Wang, Xiaoyi Jia, Jingyu Chen, Wu‐Yi Sun and Charles W. Rittershaus and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Yujing Wu

56 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yujing Wu China 19 343 337 197 182 116 63 937
M. Sanders Netherlands 14 240 0.7× 328 1.0× 229 1.2× 133 0.7× 51 0.4× 20 877
Martine Hiron France 22 261 0.8× 515 1.5× 182 0.9× 175 1.0× 91 0.8× 43 1.4k
Iraide Alloza Spain 19 532 1.6× 396 1.2× 107 0.5× 162 0.9× 51 0.4× 38 1.3k
Mingcheng Huang China 19 160 0.5× 453 1.3× 214 1.1× 139 0.8× 20 0.2× 38 931
Tiffany Telarico United States 8 334 1.0× 251 0.7× 252 1.3× 72 0.4× 37 0.3× 10 756
Antonio Tugores Spain 18 361 1.1× 550 1.6× 58 0.3× 191 1.0× 41 0.4× 57 1.3k
Haihong Qin China 18 283 0.8× 395 1.2× 142 0.7× 136 0.7× 16 0.1× 45 906
Norman A. Granholm United States 17 233 0.7× 281 0.8× 116 0.6× 166 0.9× 42 0.4× 34 918
Kazuhiko Mori Japan 16 126 0.4× 357 1.1× 30 0.2× 266 1.5× 81 0.7× 68 915

Countries citing papers authored by Yujing Wu

Since Specialization
Citations

This map shows the geographic impact of Yujing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujing Wu more than expected).

Fields of papers citing papers by Yujing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujing Wu. The network helps show where Yujing Wu may publish in the future.

Co-authorship network of co-authors of Yujing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yujing Wu. A scholar is included among the top collaborators of Yujing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujing Wu. Yujing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Tiantian, Xiaowei Li, Wei Wei, & Yujing Wu. (2025). Research progress of microneedle drug delivery system in the treatment of autoimmune diseases. Journal of drug targeting. 34(2). 185–201.
2.
Feng, Xinyu, Xianwen Wang, Ying Wang, et al.. (2024). Accelerated Screening of Alternative DNA Base‐Organic Molecule‐Base Architectures via Integrated Theory and Experiment. Angewandte Chemie International Edition. 63(35). e202408003–e202408003. 1 indexed citations
3.
Wu, Yujing, et al.. (2024). Establishment and Validation of a Blood Test-based NomogramtoDiagnose Patients with AFP-negative HCC. Current Cancer Drug Targets. 24(5). 556–564. 1 indexed citations
4.
Wu, Yujing, et al.. (2024). A case study: Lecanicillium infection detected in the human body. Diagnostic Microbiology and Infectious Disease. 109(3). 116337–116337.
6.
Liu, Shuang, et al.. (2023). Identifying Mitochondrial Transcription Factor A As a Potential Biomarker for the Carcinogenesis and Prognosis of Prostate Cancer. Genetic Testing and Molecular Biomarkers. 27(1). 5–11. 1 indexed citations
7.
Zhang, Jing, Yujing Wu, Xiaoxi Hu, & Wei Wei. (2023). New insights into the Lck-NF-κB signaling pathway. Frontiers in Cell and Developmental Biology. 11. 1120747–1120747. 4 indexed citations
8.
Gao, Lili, et al.. (2022). Case Report: A case of PLA2G6 gene-related early-onset Parkinson's disease and review of literature. Frontiers in Neuroscience. 16. 1064566–1064566. 2 indexed citations
9.
Lu, Yuan, et al.. (2021). Separation and identification of ACE inhibitory peptides from lizard fish proteins hydrolysates by metal affinity-immobilized magnetic liposome. Protein Expression and Purification. 191. 106027–106027. 16 indexed citations
10.
Hu, Xiaoxi, Aijun Zhang, Lingling Zhang, et al.. (2021). An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis. Acta Pharmacologica Sinica. 43(2). 387–400. 10 indexed citations
11.
Zhang, Jing, Xiaoxi Hu, Wensheng Chen, et al.. (2020). Regulation of T Cell Activities in Rheumatoid Arthritis by the Novel Fusion Protein IgD-Fc-Ig. Frontiers in Immunology. 11. 755–755. 18 indexed citations
12.
Jia, Xiaoyi, Yan Chang, Xiaojing Sun, et al.. (2019). Regulatory effects of paeoniflorin-6′-O-benzene sulfonate (CP-25) on dendritic cells maturation and activation via PGE2-EP4 signaling in adjuvant-induced arthritic rats. Inflammopharmacology. 27(5). 997–1010. 16 indexed citations
13.
Wu, Yujing, et al.. (2018). Relation between high density lipoprotein particles concentration and cardiovascular events: a meta-analysis. Lipids in Health and Disease. 17(1). 142–142. 14 indexed citations
14.
Yang, Xuezhi, Yingjie Zhao, Xiaoyi Jia, et al.. (2018). CP-25 combined with MTX/ LEF ameliorates the progression of adjuvant-induced arthritis by the inhibition on GRK2 translocation. Biomedicine & Pharmacotherapy. 110. 834–843. 42 indexed citations
15.
Wu, Huaxun, Jingyu Chen, Chun Wang, et al.. (2018). β2-adrenoceptor signaling reduction is involved in the inflammatory response of fibroblast-like synoviocytes from adjuvant-induced arthritic rats. Inflammopharmacology. 27(2). 271–279. 10 indexed citations
16.
Zhang, Yuanqing, Lijun Peng, Yujing Wu, et al.. (2016). Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B. Genetic Testing and Molecular Biomarkers. 20(9). 535–543. 16 indexed citations
17.
Chen, Jingyu, Qingtong Wang, Huaxun Wu, et al.. (2016). The ginsenoside metabolite compound K exerts its anti-inflammatory activity by downregulating memory B cell in adjuvant-induced arthritis. Pharmaceutical Biology. 54(7). 1280–1288. 28 indexed citations
18.
Zhang, Yuanqing, Lijun Peng, Yujing Wu, et al.. (2015). [Analysis of the risk factors of hepatocellular carcinoma in cirrhotic patients with chronic hepatitis B].. PubMed. 23(7). 512–6. 4 indexed citations
19.
Chen, Jingyu, Huaxun Wu, Qingtong Wang, et al.. (2014). Ginsenoside Metabolite Compound K Alleviates Adjuvant-Induced Arthritis by Suppressing T Cell Activation. Inflammation. 37(5). 1608–1615. 46 indexed citations
20.
Wu, Yujing. (2007). Research of Web-based integrated real-time emergency expert system framework for management and control of shipping accidents. Journal of Dalian Maritime University.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026